Small Molecule
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
96
NCT05045534
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TB-840 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 14, 2021
Completion: Dec 30, 2022
Loading map...